RxDoctor Payments Data

Teresa Jordan

Psychiatric/Mental Health · Logan, OHNPI 1235865775

Payments from drug & device makers

$2,023in general payments, 2019–2025

Across 130 payments — averaging $15.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$419
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$330
  • Teva Pharmaceuticals USA, Inc.$242
  • Johnson & Johnson$158
  • Alkermes, Inc.$146
  • Supernus Pharmaceuticals, Inc.$141
  • plus $586 from 12 others

What the payments were for

  • Food & beverage$1,97698%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,023 in reported general payments places this provider in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$20,386
Medicare patients
50
Services billed
219

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CaplytaLumateperone Tosylate50$97,475
Austedo XrDeutetrabenazine11$78,326
RexultiBrexpiprazole35$49,014
NuedextaDextromethorphan Hbr/Quinidine25$36,235
LybalviOlanzapine/Samidorphan Malate14$19,630
TrintellixVortioxetine Hydrobromide22$12,599
BelsomraSuvorexant12$5,447
Aripiprazole60$3,817
Quetiapine Fumarate ErQuetiapine Fumarate52$3,109
Olanzapine98$2,234
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine35$1,741
Quetiapine Fumarate144$1,654
Bupropion XlBupropion Hcl68$1,367
Buspirone Hcl70$1,205
Divalproex Sodium ErDivalproex Sodium42$1,047

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$330$97,47550 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr$242$78,32611 claims
Otsuka America Pharmaceutical, Inc.Rexulti$124$49,01435 claims
Alkermes, Inc.Lybalvi$146$19,63014 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$42$12,59922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Logan

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →